4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000125
Director sold 25,000 shares at $25.96 ($648,888)
- Director acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Foster-Cheek Kaye I · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-09 | Exercise or conversion : show line 1 in the form | +25,000 | $18.09 | $452,250 | 36,524 | D |
| 2023-08-09 | Sale : show line 2 in the form | −25,000 | $25.96 | $648,888 | 11,524 | D |
| Open-market sales · 25,000 sh · avg $25.96 · $648,888 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-08-09 | Exercise or conversion : show line 3 in the form Stock options (right to buy) | −25,000 | 4,307 | D |
Loading xslF345X05/wk-form4_1691784273.xml…